Results 31 to 40 of about 194,150 (247)

Cloning and characterisation of gonadotropin-releasing hormone (GnRH) receptors in the cichlid (Haplochromis burtoni) and the zebrafish (Danio rerio) [PDF]

, 2003
Bibliography: leaves 75-89.The identification of multiple forms of gonadotropin-releasing hormone (GnRH) in a single species is becoming a common occurrence.
Morley, Michelle Gaye
core   +1 more source

ICSI cycles in women over 40 years: analysis of 3 different ovarian stimulation protocols

Middle East Fertility Society Journal, 2018
Purpose: To compare the clinical and laboratory outcomes of GnRH agonist stop, aromatase inhibitor/flexible antagonist and ultrashort flare GnRHa/flexible GnRH antagonist protocols in women (40–44) years undergoing ICSI.
H. Sibai, E.A. Elgindy, M.I. Mostafa
doaj   +1 more source

Leuprorelin acetate long-lasting effects on GnRH receptors of prostate cancer cells: an atomic force microscopy study of agonist/receptor interaction. [PDF]

PLoS ONE, 2013
High cell-surface GnRH receptor (GnRH-R) levels have been shown to have a major influence on the extent of GnRH agonist-mediated tumor growth inhibition.
Gina Lama, Massimiliano Papi, Cristiana Angelucci, Giuseppe Maulucci, Gigliola Sica, Marco De Spirito   +5 more
doaj   +1 more source

The use of GnRH agonists in precocious puberty [PDF]

European Journal of Endocrinology, 2008
In this review several aspects of gonadotrophin releasing hormone agonists (GnRHa) treatment in central precocious puberty (CPP) are highlighed. These include issues of the definition of precocity, assessment of CPP and thelarche variants. Indications for treatment with GnRH agonists are discussed, not only in CPP but also in children with other ...
D, Mul, I A, Hughes
openaire   +2 more sources

Serum Anti-Müllerian Hormone Is Significantly Altered by Downregulation With Daily Gonadotropin-Releasing Hormone Agonist: A Prospective Cohort Study

Frontiers in Endocrinology, 2019
Research Question: What is the effect of gonadotropin-releasing hormone (GnRH)-agonist treatment on serum anti-Müllerian hormone (AMH)?Design: This prospective cohort study conducted in a tertiary university hospital comprised patients (n = 52) who self ...
Panagiotis Drakopoulos, Panagiotis Drakopoulos, Arne van de Vijver, Jose Parra, Ellen Anckaert, Johan Schiettecatte, Christophe Blockeel, Martin Hund, Wilma D. J. Verhagen-Kamerbeek, Ying He, Herman Tournaye, Nikolaos P. Polyzos, Nikolaos P. Polyzos, Nikolaos P. Polyzos   +13 more
doaj   +1 more source

The Effect of Coasting on Intracytoplasmic Sperm Injection Outcome in Antagonist and Agonist Cycle [PDF]

International Journal of Fertility and Sterility, 2017
Background Coasting can reduce the ovarian hyperstimulation syndrome (OHSS) risk in ovulation induction cycles before intracytoplasmic sperm injection (ICSI). This study aimed to investigate the effect of gonadotropin-releasing hormone (GnRH) agonist and
Z.Candan İltemir Duvan, Müberra Namlı Kalem, Yuksel Onaran, Esra Aktepe Keskin, Aylin Ayrım, Aslıhan Pekel, Hasan Kafalı, Nilgün Turhan   +7 more
doaj   +1 more source

Comparison of hCG Versus Gonadotropin-Releasing Hormone Agonist to Induce Oocyte Maturation in Assisted Reproductive Technology Cycles: A Retrospective Cohort Study

Gynecology Obstetrics & Reproductive Medicine, 2021
OBJECTIVE: To compare some cycle characteristics and outcomes using a protocol consisting of a GnRH agonist trigger or hCG trigger after cotreatment with GnRH antagonist. STUDY DESIGN: Thirty-three patients under 35 years of age with polycystic ovarian
Gulay Beydilli Nacak, Elif Tozkir, Enis Ozkaya, Ebru Cogendez, Fatih Kaya   +4 more
doaj   +1 more source

Outcome of Different Endometrial Preparation Protocols Prior to Frozen-Thawed Embryo Transfer on Pregnancy Outcomes in Women with Repeated Implantation Failure

International Journal of Women's Health, 2023
Yin-Ling Xiu, Kai-Xuan Sun, Qian Zhang, Yu-Hong Xiao, Xue Bai, Yong Chen, Meng-Si Zhao, Yue-Xin Yu Center of Reproductive Medicine, General Hospital of Northern Theatre Command, Shenyang, 110016, People’s Republic of ChinaCorrespondence: Yue-Xin Yu ...
Xiu YL, Sun KX, Zhang Q, Xiao YH, Bai X, Chen Y, Zhao MS, Yu YX   +7 more
doaj  

Tracking CDK1 Dynamics With a Novel Biosensor Mouse and Clinical Cohorts to Predict CDK4/6 Inhibitor Sensitivity in ER+ Breast Cancer

Advanced Science, EarlyView.
Cyclin‐dependent kinase (CDK) 1 activity is a dynamic marker of treatment response in estrogen receptor positive breast cancer. Patient cohorts reveal CDK1 activity increases during progression to invasive disease, where high expression correlates with poor survival. Using a novel Cdk1 biosensor mouse alongside in vitro models, we demonstrate that CDK1
Sarah Alexandrou, Kristine J. Fernandez, Min Li Huang, Ewan K. A. Millar, Claire Vennin, Leila Eshraghi, Tan Dat Timothy Lam, Victoria Lee, Nyah C. Brooks, Janett Stoehr, Cristian Guaman Mendez, Douglas Strathdee, David Stevenson, David Herrmann, Sandra O'Toole, Paul Timpson, Max Nobis, C. Elizabeth Caldon   +17 more
wiley   +1 more source

Ligand-induced selective signalling at the gonadotrophin releasing hormone receptor [PDF]

, 2008
Includes abstract.Includes bibliographical references (p. 179-202).The pituitary gonadotrophin releasing hormone (GnRH) receptor regulates reproduction by activation of Gq/11 proteins.
Coetsee, Marla Catherine
core   +1 more source